Nick Powell

8.0k total citations · 1 hit paper
120 papers, 3.4k citations indexed

About

Nick Powell is a scholar working on Surgery, Epidemiology and Immunology. According to data from OpenAlex, Nick Powell has authored 120 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Surgery, 39 papers in Epidemiology and 39 papers in Immunology. Recurrent topics in Nick Powell's work include Microscopic Colitis (32 papers), Inflammatory Bowel Disease (32 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Nick Powell is often cited by papers focused on Microscopic Colitis (32 papers), Inflammatory Bowel Disease (32 papers) and Cancer Immunotherapy and Biomarkers (25 papers). Nick Powell collaborates with scholars based in United Kingdom, United States and Australia. Nick Powell's co-authors include Marjorie M. Walker, Nicholas J. Talley, Graham M. Lord, Thomas T. MacDonald, Polychronis Pavlidis, Bu Hayee, Christopher J. Corrigan, B Assoufi, Jane K. Howard and Marc Humbert and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Nick Powell

109 papers receiving 3.3k citations

Hit Papers

Surface-to-space atmospheric waves from Hunga Tonga–Hunga... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nick Powell United Kingdom 30 1.1k 915 707 649 544 120 3.4k
Shirô Nakamura Japan 28 763 0.7× 696 0.8× 652 0.9× 195 0.3× 258 0.5× 193 3.1k
Joanna M. M. Howson United Kingdom 39 1.7k 1.5× 1.4k 1.5× 1.2k 1.7× 308 0.5× 351 0.6× 68 5.6k
David G. Savage United States 35 391 0.3× 1000 1.1× 1.0k 1.4× 502 0.8× 248 0.5× 114 6.4k
Maurizio Vecchi Italy 44 1.4k 1.3× 2.2k 2.5× 816 1.2× 310 0.5× 1.2k 2.2× 286 7.0k
Mark Löwenberg Netherlands 36 1.0k 0.9× 1.1k 1.2× 989 1.4× 180 0.3× 540 1.0× 166 4.9k
Morikazu Onji Japan 47 1.4k 1.2× 1.1k 1.2× 761 1.1× 555 0.9× 152 0.3× 313 7.3k
Patrizio Caturegli United States 41 1.2k 1.1× 664 0.7× 946 1.3× 456 0.7× 66 0.1× 149 6.8k
Niki Dimou Greece 18 345 0.3× 409 0.4× 887 1.3× 467 0.7× 106 0.2× 40 3.8k
Jun Oh Germany 31 543 0.5× 482 0.5× 858 1.2× 236 0.4× 65 0.1× 159 4.0k
Masaki Fujimura Japan 37 418 0.4× 851 0.9× 720 1.0× 2.4k 3.7× 307 0.6× 378 5.8k

Countries citing papers authored by Nick Powell

Since Specialization
Citations

This map shows the geographic impact of Nick Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Powell more than expected).

Fields of papers citing papers by Nick Powell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nick Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Powell. The network helps show where Nick Powell may publish in the future.

Co-authorship network of co-authors of Nick Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Nick Powell. A scholar is included among the top collaborators of Nick Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nick Powell. Nick Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabrera, Claudia, Marita Olsson, Elizabeth A. Duncan, et al.. (2025). Plasma interleukin-22 concentration and disease activity in inflammatory bowel disease. Scientific Reports. 15(1). 30399–30399.
2.
Mullish, Benjamin H., Márton Ölbei, Nathan Danckert, et al.. (2025). Deciphering the microbiome–metabolome landscape of an inflammatory bowel disease inception cohort. Gut Microbes. 17(1). 2527863–2527863. 2 indexed citations
3.
Qureshi, Kristine, L. Roberts, Nick Powell, et al.. (2025). The emerging role of the gut microbiota in vaccination responses. Gut Microbes. 17(1). 2549585–2549585.
4.
Sands, Bruce E., Laurent Peyrin‐Biroulet, Silvio Danese, et al.. (2025). Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 14(13). 4419–4419.
5.
Kirchgesner, Julien, Bram Verstockt, Michel Adamina, et al.. (2025). ECCO Topical Review on Predictive Models on Inflammatory Bowel Disease Disease Course and Treatment Response. Journal of Crohn s and Colitis. 19(6). 2 indexed citations
6.
Ibraheim, Hajir, et al.. (2024). The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy. Best Practice & Research Clinical Gastroenterology. 72. 101944–101944. 3 indexed citations
7.
Lo, Jonathan W., Luke B. Roberts, Domenico Cozzetto, et al.. (2024). CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner. Nature Communications. 15(1). 9520–9520. 6 indexed citations
8.
Stolarczyk, Émilie, Chi Teng Vong, Natividad Garrido‐Mesa, et al.. (2024). Global deletion of the immune cell transcription factor, T-bet, alters gut microbiota and insulin sensitivity in mice. Frontiers in Genetics. 15. 1502832–1502832. 1 indexed citations
9.
Liebert, Anke, Michael Shapiro, Muralidhara Rao Maradana, et al.. (2023). Dysregulation of the Environmental Sensor Aryl Hydrocarbon Receptor Affects Differentiation of Human Colon Organoids. Cellular and Molecular Gastroenterology and Hepatology. 17(3). 507–510. 1 indexed citations
10.
Lo, Jonathan W., Domenico Cozzetto, James L. Alexander, et al.. (2023). Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis. Nature Communications. 14(1). 6719–6719. 15 indexed citations
11.
Pavlidis, Polychronis, Anastasia Tsakmaki, Agatha Treveil, et al.. (2022). Cytokine responsive networks in human colonic epithelial organoids unveil a molecular classification of inflammatory bowel disease. Cell Reports. 40(13). 111439–111439. 22 indexed citations
12.
Pavlidis, Polychronis, Deepak Joshi, Ben Warner, et al.. (2022). Faecal calprotectin is a surrogate marker of biliary inflammation in primary sclerosing cholangitis associated inflammatory bowel disease. Frontline Gastroenterology. 13(6). 497–502. 1 indexed citations
13.
Alexander, James L., Hajir Ibraheim, Benjamin Shum, et al.. (2022). Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis. Journal for ImmunoTherapy of Cancer. 10(9). e005490–e005490. 6 indexed citations
15.
Alexander, James L., Benjamin H. Mullish, Kate Gallagher, et al.. (2021). Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 55(1). 26–48. 33 indexed citations
16.
Schmitz, Jochen, Nick Powell, Klaus Gottlieb, et al.. (2020). DOP65 Mirikizumab regulates genes involved in anti-TNF resistance and ulcerative colitis disease activity. Journal of Crohn s and Colitis. 14(Supplement_1). S103–S104. 3 indexed citations
17.
Ibraheim, Hajir, Chiara Giacomini, Zain Kassam, Francesco Dazzi, & Nick Powell. (2017). Advances in mesenchymal stromal cell therapy in the management of Crohn’s disease. Expert Review of Gastroenterology & Hepatology. 12(2). 141–153. 17 indexed citations
18.
Kariyawasam, Harsha H., Batika M.J. Rana, Stephen R. Durham, et al.. (2015). IL-25/IL-33–responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa. Journal of Allergy and Clinical Immunology. 137(5). 1514–1524. 69 indexed citations
19.
Goldberg, Rimma, Natalie J. Prescott, Graham M. Lord, Thomas T. MacDonald, & Nick Powell. (2015). The unusual suspects—innate lymphoid cells as novel therapeutic targets in IBD. Nature Reviews Gastroenterology & Hepatology. 12(5). 271–283. 77 indexed citations
20.
Soderquest, Katrina, Nick Powell, Carmelo Luci, et al.. (2011). Monocytes control natural killer cell differentiation to effector phenotypes. Blood. 117(17). 4511–4518. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026